- MFG # N/A
- UPC # 894173000048
Femarelle is a clinically proven treatment with published studies in leading medical journals.
Published studies have shown:
Efficacy of Femarelle:
-Femarelle combines menopausal symptoms relief and bone health.
-Relief is felt within the first month of treatment.
-Symptoms relief is felt by 3 out of 4 women.
-Femarelle increases Bone Mineral Density (BMD).
-Femarelle exhibits unique bone-forming properties by increasing bone formation through osteoblast activity‚ thus inducing bone rejuvenation.
-Femarelle was shown to be effective for vaginal dryness (atrophy).
Safety of Femarelle:
-Femarelle was shown not to affect clotting even in thrombophilic patients.
-Femarelle does not affect the breast tissue.
-Femarelle does not affect the uterus and the endometria.
-Femarelle does not affect the Thyroid Stimulating Hormone (TSH).
-Femarelle does not affect liver and kidney functions.
-Femarelle does not affect the hormonal blood profile.
-Femarelle does not induce proliferation of hormone dependant breast cancer cells.
-Furthermore‚ in the studies and in the data accumulated up to date no serious adverse events have been reported.
Femarelle's uniqueness lies in its being a Selective Estrogen Receptor Modulator- a SERM. The selectivity in the estrogen receptor bondage provides both menopausal symptoms relief and bone health‚ without affecting the sensitive tissues in the breast and uterus.
Thus‚ Femarelle provides a safe and effective solution for the management of menopause.
The scientific activity surrounding Femarelle has been published in leading scientific journals worldwide and has received international recognition and acceptance by the medical community both in their practices and in leading medical conventions.
The research process continues and new studies are constantly being conducted in order to provide comprehensive data proving both the efficacy and safety of use of Femarelle.
Studies have shown that Femarelle stimulates estrogen receptors in specific tissues‚ alleviating menopausal symptoms and inducing bone formation‚ while having no negative effect on the uterus and the breast tissue.
Clinical studies show that Femarelle provides fast-acting relief‚ alleviating menopausal symptoms‚ such as hot flushes‚ headaches‚ sleep disturbances and joint and muscle discomfort.
Furthermore‚ Femarelle has been proven to increase bone mineral density and the unique bone-forming mechanism through the promotion of osteoblast activity leads to new bone formation. Thus‚ Femarelle provides bone strength and maintains bone health.
In addition to the proven efficacy‚ studies also demonstrate the safety of Femarelle.
Since Femarelle acts as a SERM‚ it is able to target various parts of the body‚ relieving menopausal symptoms and promoting bone health‚ while having no effect on breast and uterine tissue.
Femarelle has also been proven to have no effect on the clotting even in thrombophilic women.
Femarelle has been in the market since the year 2000 and to date with over 3 Million months of use‚ no serious adverse events have been reported with the use of Femarelle.
In a recent clinical study Femarelle was shown to be an exceptionally effective agent for vaginal dryness (atrophy)‚ a condition that 75% of postmenopausal women suffer from.
Femarelle's positive effect on menopausal symptoms and its great improvement on women's quality of life can be felt within the first month of treatment.
Femarelle offers a clinically proven‚ safe and effective solution for the management of menopause and bone health.
These statements have not been evaluated by the Food and Drug Administration (FDA). These products are not meant to diagnose‚ treat or cure any disease or medical condition. Please consult your doctor before starting any exercise or nutritional supplement program or before using these or any product during pregnancy or if you have a serious medical condition.
Each capsule contains 322 mg. of DT56a (a unique compound derived from soy) and 108 mg. of grounded flaxseed.
Femarelle is intended for women from the time they reach peri-menopause and onward. The therapeutic indication is the relief of menopausal symptoms and bone health.
Femarelle should be taken twice a day‚ one capsule in the morning and one in the evening. Swallow the capsule with some water. Femarelle can be taken with or without food. It is important that you take two capsules a day as this is the required dose for optimal benefit particularly for bone health.
Consult a healthcare professional before use.